Title : Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia.

Pub. Date : 2008 Nov 10

PMID : 18854573






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia. Mitoxantrone CD33 molecule Homo sapiens